What happened in this case?
An appeal in the United States Court of Appeals for the First Circuit between Amyndas Pharmaceuticals, S.A., et al and Zealand Pharma A/S, et al. The court issued a decision on Sep. 2, 2022.
United States Court of Appeals for the First Circuit
Where this case stands
The side that appealed won, at least for now. The court ruled against the lower court's decision.
In the court's words:
“We vacate the dismissal of Amyndas's claims against Zealand US and remand for further proceedings consistent with this opinion.”
The lower court's ruling was wiped out, as if it had not been issued. The case goes back to the lower court to continue in line with this ruling.
Jurvio has no record of a later decision overruling it. Our citation records are not complete, so this is not a guarantee.
Plain-English summary, not legal advice. Generated from the court record by fixed rules; quotes are the court's own words. If the record doesn't say, we say so instead of guessing.
Quick answers
Short answers drawn from the court record. If the record doesn't say, we leave it out rather than guess.
An appeal in the United States Court of Appeals for the First Circuit between Amyndas Pharmaceuticals, S.A., et al and Zealand Pharma A/S, et al. The court issued a decision on Sep. 2, 2022.
The latest dated event in the record is “Decision issued” on Sep. 2, 2022.
The court issued its decision on Sep. 2, 2022. The full text of the opinion is available on this page.
Sep. 2, 2022: Decision issued
Understand this case
Amyndas Pharmaceuticals, S.A., et al v Zealand Pharma A/S, et al is United States Court of Appeals for the First Circuit case number 21-01781. Jurvio currently provides 1 readable court document for this case.
Opinion type: Majority opinionThe opinion expressing the reasoning supported by most judges deciding the case.Learn more about majority opinion →
Cites 66 cases · 7 on Jurvio
Available court materials
Court documents Jurvio has for this case. More will appear here as we add them.